For the Inventor, By the Inventor

Enter inventor name

Stevenson Ranch, CA, United States of America

Thomas P Hedman

USPTO Granted Patents = 16 (Patent Applications = 4)

CIPO Patents = 3

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 1.5

ph-index = 6

Forward Citations = 79(Granted Patents)

Location History:

Georgetown, TX (US) (2012)
Stevenson Ranch, CA (US) (2008 - 2015)
Lexington, KY (US) (2012 - 2021)

Company Filing History:

Orthopeutics, L.p.

University of Southern California

Spinal Simplicity, LLC

Years Active: 2008-2025

Loading Chart...

Loading Chart...

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12186199 - Shield for spinal defect (2025-01-07),

2. 10980771 - Crosslinker enhanced repair of connective tissues (2021-04-20),

3. 10278947 - Crosslinker enhanced repair of connective tissues (2019-05-07),

4. 9918870 - Tissue crosslinking for treatment of snoring and obstructive sleep apnea (2018-03-20),

5. 9492592 - Crosslinker enhanced repair of knee meniscus (2016-11-15),

6. 9192507 - Tissue crosslinking for treatment of snoring and obstructive sleep apnea (2015-11-24),

7. 9101602 - Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissues (2015-08-11),

8. 9084772 - Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissues (2015-07-21),

9. 8450276 - Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability (2013-05-28),

10. 8283322 - Formulations for nonsurgical exogenous crosslink therapy (2012-10-09),

11. 8211938 - Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity (2012-07-03),

12. 8198248 - Formulations for nonsurgical exogenous crosslink therapy (2012-06-12),

13. 8153600 - Direct application of non-toxic crosslinking reagents to resist progressive spinal deformity (2012-04-10),

14. 8119599 - Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity (2012-02-21),

15. 8022101 - Method of treating a knee meniscus with a cross-linking reagent to increase resistance to tearing or rupturing (2011-09-20),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…